How do I initiate levothyroxine therapy, including starting dose and administration guidelines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How to Start Levothyroxine

For young healthy adults with overt hypothyroidism, start with full replacement dosing of approximately 1.6 µg/kg/day (typically 100-125 µg daily), while patients over 50-60 years should start at 50 µg daily, and those with known coronary heart disease should begin at 12.5-25 µg daily. 1

Starting Dose Algorithm

Patient Age and Cardiac Status Determine Initial Dose

Young, healthy adults (<50 years, no cardiac disease):

  • Start at full replacement: 1.6 µg/kg/day based on ideal body weight 1
  • Typical starting doses: 100-125 µg daily
  • This achieves faster TSH normalization without delaying symptom resolution 1

Older adults (>50-60 years, no cardiac disease):

  • Start at 50 µg daily 1
  • Elderly patients require 20-25% less per kilogram due to decreased lean body mass 1

Patients with known coronary heart disease or at risk for atrial fibrillation:

  • Start at 12.5-25 µg daily 1, 2
  • Titrate more slowly to avoid exacerbating cardiac symptoms
  • Monitor closely for anginal symptoms 1

Subclinical Hypothyroidism Requires Lower Doses

For subclinical hypothyroidism, use TSH-guided dosing:

  • TSH 4.0-8.0 mIU/L: Start 25 µg daily 1
  • TSH 8-12 mIU/L: Start 50 µg daily 1
  • TSH >12 mIU/L: Start 75 µg daily 1
  • This approach achieves euthyroidism with minimal adjustments after 2 months 1

The guideline evidence 1 explicitly recommends 25-75 µg daily for subclinical hypothyroidism, with higher doses needed for higher TSH values.

Administration Instructions

Timing is critical for optimal absorption:

  • Take with water 30-60 minutes before breakfast on an empty stomach, OR
  • Take at bedtime, 4 hours after the last meal 1, 2
  • Both methods are acceptable; choose based on patient compliance 1

Key absorption considerations:

  • Administer at least 4 hours apart from medications that interfere with absorption (calcium, iron, proton pump inhibitors, bile acid sequestrants) 2
  • Avoid taking with soybean products, dietary fiber, or within 1 hour of meals that may affect absorption 2
  • For patients unable to swallow tablets: crush and suspend in 5-10 mL water, administer immediately 2

Monitoring and Titration

Check TSH 4-8 weeks after initiation:

  • Peak therapeutic effect takes 4-6 weeks to manifest 2
  • Adjust dose in 12.5-25 µg increments 1
  • Smaller doses may require 8 weeks or longer before TSH plateaus 1

Target TSH for primary hypothyroidism:

  • Normalize TSH to reference range 2
  • For secondary/tertiary hypothyroidism, use free T4 (target upper half of normal range) instead of TSH 2

Special Populations

Pregnancy:

  • Women with hypothyroidism who become pregnant should immediately increase their weekly dose by 30% (take 9 doses per week instead of 7, or one extra dose twice weekly) 3
  • Target TSH <2.5 mIU/L in first trimester, <3.0 mIU/L in second trimester, <3.5 mIU/L in third trimester 1
  • Monitor TSH every 4 weeks during first half of pregnancy 1

Post-thyroidectomy patients:

  • May require higher doses (closer to 1.6 µg/kg) due to complete absence of thyroid tissue 1
  • Recent evidence shows early postoperative weight changes significantly influence dose requirements 4

Common Pitfalls to Avoid

Incorrect administration technique is extremely common:

  • A 2025 study found 77.4% of patients used incorrect technique 5
  • Among patients with elevated TSH and incorrect technique, only 58.8% actually needed dose escalation after technique correction 5
  • Always verify administration technique before adjusting dose 5

Overtreatment risks:

  • Occurs in approximately 20% of treated patients 1
  • Increases risk of atrial fibrillation (especially in elderly), bone loss (postmenopausal women), and cardiovascular complications 1
  • Avoid TSH suppression unless treating thyroid cancer 2

Drug interactions:

  • Many medications affect levothyroxine absorption or metabolism 1
  • Recheck TSH 4-8 weeks after starting medications that alter bioavailability 1

Storage:

  • Store at 20-25°C (68-77°F), protected from light and moisture 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.